• 17150 Citations
  • 65 Scopus h-Index
19962020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Susan L Slager is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

  • Research Output

    Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare

    Hampel, P. J., Call, T. G., Ding, W., Muchtar, E., Kenderian, S. S., Wang, Y., Leis, J. F., Witzig, T. E., Koehler, A. B., Fonder, A. L., Schwager, S. M., Rabe, K. G., Van Dyke, D. L., Braggio, E., Slager, S. L., Kay, N. E. & Parikh, S. A., Mar 1 2020, In : American journal of hematology. 95, 3, p. E57-E60

    Research output: Contribution to journalLetter

    Open Access

    Clinical characteristics and outcomes of Richter transformation: Experience of 204 patients from a single center

    Wang, Y., Tschautscher, M. A., Rabe, K. G., Call, T. G., Leis, J. F., Kenderian, S. S., Kay, N. E., Muchtar, E., van Dyke, D. L., Koehler, A. B., Schwager, S. M., Slager, S. L., Parikh, S. A. & Ding, W., Mar 1 2020, In : Haematologica. 105, 3, p. 765-773 9 p.

    Research output: Contribution to journalArticle

    Open Access
  • 4 Scopus citations

    Correction to: Infectious mononucleosis, immune genotypes, and non-Hodgkin lymphoma (NHL): an InterLymph Consortium study (Cancer Causes & Control, (2020), 31, 5, (451-462), 10.1007/s10552-020-01266-4)

    for the InterLymph Consortium Immunology and Infection Working Group, Jan 1 2020, (Accepted/In press) In : Cancer Causes and Control. 31, 6, 1 p.

    Research output: Contribution to journalComment/debate

    Open Access
  • Infectious mononucleosis, immune genotypes, and non-Hodgkin lymphoma (NHL): an InterLymph Consortium study

    for the InterLymph Consortium Immunology and Infection Working, May 1 2020, In : Cancer Causes and Control. 31, 5, p. 451-462 12 p.

    Research output: Contribution to journalArticle

  • Risk of serious infection among individuals with and without low count monoclonal B-cell lymphocytosis (MBL)

    Shanafelt, T. D., Kay, N. E., Parikh, S. A., Achenbach, S. J., Lesnick, C. E., Hanson, C. A., Kleinstern, G., Olson, J. E., Norman, A. D., Rabe, K. G., Schwager, S. M., Call, T. G. & Slager, S. L., Jan 1 2020, (Accepted/In press) In : Leukemia.

    Research output: Contribution to journalLetter

    1 Scopus citations